Drug Kinetics – News and Features

Professor Dame Ijeoma Uchegbu discusses the nanoparticle delivery system behind the non-addictive pain medication Envelta and how this treatment could help overcome issues surrounding efficacy and off-target effects.

Discover the science of rheology—exploring how materials flow and deform, essential for industries like food, polymers and pharmaceuticals, and gain key insights into viscosity, elasticity and practical testing techniques.

Scientists have found a way to combat a rare, aggressive form of cancer affecting pregnant women and to better ensure the drug used for the disease reaches tumor cells without damaging healthy tissue.

Researchers have revealed novel sequence-structure-property relationships for customizing engineered living materials, enabling more precise control over their structure and how they respond to force.

New research challenges previous assumptions about RNA transport, finding that RNA can carry instructions across generations.

UIC researchers have redesigned asparaginase, a key leukemia treatment, to reduce severe side effects like liver damage and blood clots. The modified enzyme is more effective and may treat other cancers like melanoma.

A carnation-like nanostructure demonstrates antibiotic and anti-inflammatory properties when included in bandages.

A nanotechnology-based drug delivery system developed at UVA Health to save patients from repeated surgeries has proved to have unexpectedly long-lasting benefits in lab tests – a promising sign for its potential to help human patients.

Prokaryotes are unicellular organisms that lack membrane-bound structures. This article details the structure of prokaryotic cells and provides examples of prokaryotic organisms.

Researchers have combined injections of a novel hydrogel with systemic osteoporosis drugs in rats, achieving rapid local increases in bone density. The results offer hope for future fracture prevention therapies in osteoporosis patients.